DLA Piper advised diagnostic imaging and oncological treatment network Affidea on its acquisition of the Medisport Medical Center in Lublin. Gessel advised MediSport majority shareholder Adam Lewczyk on the sale.
Life Sciences Bulletin: Recent notable changes to life sciences regulation in Hungary
A reorganisation of the authorities regulating the pharma sector and new legislative pieces have brought notable changes to the life sciences sector in Hungary.
NKO Partners Advises Dr. Max on Acquisition of Pet-Sar Farm
NKO Partners has advised the Dr. Max pharmacy chain on its acquisition of the Pet-Sar Farm pharmacy chain in Serbia from Natasa Stanojkovic.
SK&S and Loewen Advise on Velocity Clinical Research Acquisition of ClinMedica Research
SK&S Soltysinski Kawecki & Szlezak has advised Velocity Clinical Research on its acquisition of ClinMedica Research. Loewen Kaczmarek Zawadowski advised Deo Family Fundacja Rodzinna on the sale.
Glatzova & Co Advises on Sale of Jarident and Janouch Dental to Nuent Group
Glatzova & Co has advised the shareholders of Jarident and Janouch Dental on the sale of the companies to the Nuent Group.
KSB Advises on Sale of Anesan
Kocian Solc Balastik has advised the owners of Anesan on its sale to Penta Hospitals. The Evan law firm reportedly advised Penta Hospitals.
Prague Alert - Amendment to the Medicines Act
Dear readers, during the New Year's rush, it may have escaped your attention that on 29 December, the Amendment to the Medicines Act was published in the Collection of Laws, in volume 203 under number 456/2023 Coll. Barring one exception, which we discuss below, the amendment already went into effect on 1 January 2024.